UBE2L5
gene geneOn this page
Summary
UBE2L5 (ubiquitin conjugating enzyme E2 L5, HGNC:13477) is a protein-coding gene on chromosome 13q12.3, encoding Ubiquitin-conjugating enzyme E2 L5 (A0A1B0GUS4). Catalyzes the covalent attachment of ubiquitin to other proteins.
Predicted to enable ubiquitin conjugating enzyme activity. Predicted to be involved in protein K11-linked ubiquitination and ubiquitin-dependent protein catabolic process. Predicted to be active in nucleus.
Source: NCBI Gene 171222 — RefSeq curated summary.
At a glance
- MANE Select transcript:
NM_001355247
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13477 |
| Approved symbol | UBE2L5 |
| Name | ubiquitin conjugating enzyme E2 L5 |
| Location | 13q12.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000236444 |
| Ensembl biotype | protein_coding |
| Entrez | 171222 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000436446, ENST00000635918, ENST00000638137
RefSeq mRNA: 1 — MANE Select: NM_001355247
NM_001355247
CCDS: CCDS86346
Canonical transcript exons
ENST00000635918 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003798135 | 30426725 | 30426778 |
| ENSE00003798886 | 30427361 | 30429758 |
| ENSE00003799724 | 30422493 | 30422677 |
| ENSE00003800889 | 30424808 | 30424901 |
Expression profiles
Bgee: expression breadth ubiquitous, 115 present calls, max score 89.31.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1682 / max 58.1497, expressed in 39 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 134612 | 0.1334 | 38 |
| 206992 | 0.0348 | 1 |
Top tissues by expression
126 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 89.31 | gold quality |
| testis | UBERON:0000473 | 88.54 | gold quality |
| right testis | UBERON:0004534 | 88.20 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.14 | gold quality |
| right coronary artery | UBERON:0001625 | 60.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 57.83 | gold quality |
| left uterine tube | UBERON:0001303 | 56.66 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 56.14 | gold quality |
| cortical plate | UBERON:0005343 | 55.29 | silver quality |
| tibial artery | UBERON:0007610 | 55.08 | gold quality |
| popliteal artery | UBERON:0002250 | 55.05 | gold quality |
| body of uterus | UBERON:0009853 | 54.91 | gold quality |
| calcaneal tendon | UBERON:0003701 | 54.34 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 53.50 | gold quality |
| prefrontal cortex | UBERON:0000451 | 52.78 | gold quality |
| myometrium | UBERON:0001296 | 52.30 | gold quality |
| thoracic aorta | UBERON:0001515 | 52.21 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 52.21 | gold quality |
| ascending aorta | UBERON:0001496 | 52.09 | gold quality |
| ectocervix | UBERON:0012249 | 51.97 | gold quality |
| endocervix | UBERON:0000458 | 51.67 | gold quality |
| uterine cervix | UBERON:0000002 | 51.63 | gold quality |
| endometrium | UBERON:0001295 | 51.40 | gold quality |
| frontal cortex | UBERON:0001870 | 50.74 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 50.71 | gold quality |
| left coronary artery | UBERON:0001626 | 50.61 | gold quality |
| lymph node | UBERON:0000029 | 50.44 | gold quality |
| muscle tissue | UBERON:0002385 | 49.26 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 48.89 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 48.87 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.19 |
Regulation
Is transcription factor: no
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ube2l3b | ENSDARG00000027141 |
| danio_rerio | ube2l3a | ENSDARG00000112087 |
| mus_musculus | Ube2l3 | ENSMUSG00000038965 |
| rattus_norvegicus | Ube2l3 | ENSRNOG00000001862 |
Paralogs (12): UBE2D1 (ENSG00000072401), UBE2D4 (ENSG00000078967), UBE2D3 (ENSG00000109332), UBE2D2 (ENSG00000131508), UBE2Q2 (ENSG00000140367), UBE2L6 (ENSG00000156587), UBE2Q1 (ENSG00000160714), UBE2E3 (ENSG00000170035), UBE2E1 (ENSG00000170142), UBE2E2 (ENSG00000182247), UBE2L3 (ENSG00000185651), UBE2QL1 (ENSG00000215218)
Protein
Protein identifiers
Ubiquitin-conjugating enzyme E2 L5 — A0A1B0GUS4 (reviewed: A0A1B0GUS4)
Alternative names: Ubiquitin-protein ligase L5
All UniProt accessions (1): A0A1B0GUS4
UniProt curated annotations — full annotation on UniProt →
Function. Catalyzes the covalent attachment of ubiquitin to other proteins.
Pathway. Protein modification; protein ubiquitination.
Similarity. Belongs to the ubiquitin-conjugating enzyme family.
RefSeq proteins (1): NP_001342176* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000608 | UBC | Domain |
| IPR016135 | UBQ-conjugating_enzyme/RWD | Homologous_superfamily |
| IPR023313 | UBQ-conjugating_AS | Active_site |
| IPR050113 | Ub_conjugating_enzyme-E2-like | Family |
Pfam: PF00179
UniProt features (3 total): chain 1, domain 1, active site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GUS4-F1 | 93.77 | 0.91 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 86 (glycyl thioester intermediate)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 21 (showing top):
GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_PROTEIN_K11_LINKED_UBIQUITINATION, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_PROTEIN_POLYUBIQUITINATION, GOBP_PROTEIN_CATABOLIC_PROCESS, GOBP_PROTEOLYSIS, GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_ADENYL_NUCLEOTIDE_BINDING, CHAF1B_TARGET_GENES, SFMBT1_TARGET_GENES, ZNF92_TARGET_GENES, GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION, NFXL1_TARGET_GENES
GO Biological Process (4): ubiquitin-dependent protein catabolic process (GO:0006511), protein K11-linked ubiquitination (GO:0070979), protein ubiquitination (GO:0016567), protein modification by small protein conjugation (GO:0032446)
GO Molecular Function (6): ATP binding (GO:0005524), ligase activity (GO:0016874), ubiquitin conjugating enzyme activity (GO:0061631), nucleotide binding (GO:0000166), transferase activity (GO:0016740), ubiquitin-like protein transferase activity (GO:0019787)
GO Cellular Component (1): nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| catalytic activity | 2 |
| protein ubiquitination | 1 |
| modification-dependent protein catabolic process | 1 |
| protein polyubiquitination | 1 |
| protein modification by small protein conjugation | 1 |
| protein modification by small protein conjugation or removal | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| ubiquitin-protein transferase activity | 1 |
| ubiquitin-like protein conjugating enzyme activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| aminoacyltransferase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
1337 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| UBE2L5 | RNF214 | Q8ND24 | 525 |
| UBE2L5 | TATDN2 | Q93075 | 480 |
| UBE2L5 | TM2D1 | Q9BX74 | 416 |
| UBE2L5 | OAZ2 | O95190 | 400 |
| UBE2L5 | TMCC3 | Q9ULS5 | 379 |
| UBE2L5 | OST4 | P0C6T2 | 369 |
| UBE2L5 | ARIH2 | O95376 | 367 |
| UBE2L5 | SLITRK2 | Q9H156 | 363 |
| UBE2L5 | USP48 | Q86UV5 | 355 |
| UBE2L5 | GPRIN3 | Q6ZVF9 | 351 |
| UBE2L5 | INTS10 | Q9NVR2 | 350 |
| UBE2L5 | ZNF579 | Q8NAF0 | 336 |
| UBE2L5 | NFATC2IP | Q8NCF5 | 335 |
| UBE2L5 | TCF19 | Q9Y242 | 330 |
| UBE2L5 | RNF6 | Q9Y252 | 330 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GUS4, A5PJC4, A5PKP9, D3ZDK2, O13685, O14933, O74196, O74549, P15731, P15732, P25867, P35129, P35131, P35132, P35133, P35134, P35135, P43102, P51668, P52487, P60604, P60605, P61080, P62837, P62838, P62839, P62840, P68036, P68037, P70711, Q17QG5, Q1RMX2, Q21633, Q2TA10, Q3MHP1, Q3ZCF7, Q4V8J2, Q5R5I4, Q5RF84, Q6C9W0
Diamond homologs: A0A1B0GUS4, A5PJC4, A5PKP9, D3ZDK2, O13685, O14933, O74196, O74810, P0C8G3, P0C8G4, P0C8G5, P15731, P15732, P21734, P25867, P25869, P27949, P35128, P35129, P35131, P35132, P35133, P35134, P35135, P43102, P46595, P49427, P51668, P51965, P52482, P52483, P52485, P52487, P52490, P52492, P61077, P61078, P61079, P61080, P61088
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| “Ub:E1 (UBA1 substrate)” | “up-regulates activity” | UBE2L5 | ubiquitination |
| “Ub:E1 (UBA6 substrate)” | “up-regulates activity” | UBE2L5 | ubiquitination |
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1030 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:30428275:G:C | W95C | 0.995 |
| 13:30428275:G:T | W95C | 0.995 |
| 13:30428273:T:A | W95R | 0.994 |
| 13:30428273:T:C | W95R | 0.994 |
| 13:30428396:T:C | F136L | 0.993 |
| 13:30428398:C:A | F136L | 0.993 |
| 13:30428398:C:G | F136L | 0.993 |
| 13:30428141:T:C | F51L | 0.992 |
| 13:30428143:C:A | F51L | 0.992 |
| 13:30428143:C:G | F51L | 0.992 |
| 13:30428007:G:T | R6M | 0.991 |
| 13:30428093:T:A | W35R | 0.991 |
| 13:30428093:T:C | W35R | 0.991 |
| 13:30428218:C:A | H76Q | 0.988 |
| 13:30428218:C:G | H76Q | 0.988 |
| 13:30428217:A:G | H76R | 0.987 |
| 13:30428008:G:C | R6S | 0.986 |
| 13:30428008:G:T | R6S | 0.986 |
| 13:30428142:T:C | F51S | 0.986 |
| 13:30428216:C:G | H76D | 0.986 |
| 13:30428274:G:C | W95S | 0.985 |
| 13:30428177:T:C | F63L | 0.984 |
| 13:30428179:C:A | F63L | 0.984 |
| 13:30428179:C:G | F63L | 0.984 |
| 13:30428313:T:C | L108P | 0.983 |
| 13:30428409:C:A | A140D | 0.982 |
| 13:30428274:G:T | W95L | 0.981 |
| 13:30428018:G:A | E10K | 0.979 |
| 13:30428205:C:T | T72I | 0.979 |
| 13:30428007:G:C | R6T | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000305236 (13:30427758 G>C), RS1000447112 (13:30420536 G>T), RS1001095716 (13:30427071 T>C), RS1001223022 (13:30421592 A>G), RS1001393913 (13:30427849 A>T), RS1001423614 (13:30428124 C>G,T), RS1001428139 (13:30428637 G>A), RS1001652237 (13:30421351 T>C), RS1001715270 (13:30421809 C>A,G,T), RS1002222825 (13:30421926 C>G,T), RS1002427871 (13:30426501 A>G), RS1002985843 (13:30423899 C>T), RS1003101521 (13:30429731 A>G), RS1003134137 (13:30429942 C>T), RS1003235275 (13:30425158 C>A,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.